ImmunoPrecise Antibodies (STU:TQB) Equity-to-Asset : 0.55 (As of Jan. 2025)

ImmunoPrecise Antibodies Equity-to-Asset Chart

ImmunoPrecise Antibodies Annual Data
	Trend	Dec14	Dec15	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
Equity-to-Asset		Get a 7-Day Free Trial					0.55	0.85	0.80	0.74	0.57

ImmunoPrecise Antibodies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Equity-to-Asset	Get a 7-Day Free Trial															0.63	0.57	0.55	0.55	0.55

Competitive Comparison of ImmunoPrecise Antibodies's Equity-to-Asset

For the Biotechnology subindustry, ImmunoPrecise Antibodies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunoPrecise Antibodies's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's Equity-to-Asset falls into.

ImmunoPrecise Antibodies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

ImmunoPrecise Antibodies's Equity to Asset Ratio for the fiscal year that ended in Apr. 2024 is calculated as

ImmunoPrecise Antibodies's Equity to Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunoPrecise Antibodies  (STU:TQB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

ImmunoPrecise Antibodies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description